March 2026
1. MIAO Z, Yang Z, Huang Q, Fan J, et al
   Ding-zhi-xiao-wan attenuates Alzheimer's disease pathology and cognitive deficits in mouse model.
   Brain Res. 2026;1881:150263.
   

   >> Share

   
   
2. LI J, Wang C, Zhang JH, Cai JM, et al
   Retraction notice to "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress" [Brain Res. 1328 (2010) 152-161].
   Brain Res. 2026 Mar 6:150251. doi: 10.1016/j.brainres.2026.150251.
   

   >> Share

   
   
3. CORIA-LUCERO C, Lopez M, Gomez-Mejiba S, Ramirez D, et al
   Daily temporal organization of inflammation and cognition-related factors and antioxidant enzymes are modified by an intracerebroventricular injection of amyloid-beta peptide (1-42) aggregates in the rat temporal cortex.
   Brain Res. 2026;1874:150135.
   

   >> Share

   
   February 2026
4. ZHENG M, Su W, Tian L, Gao W, et al
   The glymphatic system as a brain scavenger in Alzheimer's disease: mechanisms and therapeutic implications.
   Brain Res. 2026;1880:150221.
   

   >> Share

   
   
5. MANASA M, Bethanagere Ramesha G, Krishna KL, Ambika MS, et al
   Harnessing estrogen's neuroprotective potential in mitigating Alzheimer's pathologies in postmenopausal women: a review.
   Brain Res. 2026;1879:150226.
   

   >> Share

   
   January 2026
6. CADAXO AS, Cotrin JC, Valente AP, Lopes FG, et al
   Multi-biofluid metabolomics coupled with gene network reveals stage-specific alterations in mild cognitive impairment and Alzheimer's disease in an ethnically mixed cohort.
   Brain Res. 2026;1874:150167.
   

   >> Share

   
   
7. PARIYA GHOLIZADEH DANGHERALOU , Khazaeifard F, Mehr SR, Mansouri SM, et al
   Evaluation of neurobiochemical and behavioral responses to carvone nanoemulsion: A neuroprotective approach for Alzheimer's disease-associated dementia in a rat model.
   Brain Res. 2026 Jan 2:150143. doi: 10.1016/j.brainres.2026.150143.
   

   >> Share

   
   
8. WU H, Liu L, Zeng L
   Advances in plasma biomarkers for the diagnosis of Alzheimer's disease.
   Brain Res. 2026;1874:150138.
   

   >> Share

   
   December 2025
9. YUAN J, Zhang J, Zhang H, Tu Y, et al
   Propofol induces mitochondrial dysfunction in hippocampal neurons and postoperative cognitive dysfunction in male 3xTg-AD mice by blocking ESRRG-mediated HSD11B2 transcription.
   Brain Res. 2025;1869:150035.
   

   >> Share

   
   
10. MAJUMDER M, Dutta D, Paidi RK, Pahan K, et al
    Activation of PPARalpha by gemfibrozil lowers tau-associated neuropathology in the MAPT mouse model of Alzheimer's disease.
    Brain Res. 2025 Dec 7:150089. doi: 10.1016/j.brainres.2025.150089.
    

    >> Share

    
    
11. REYES H, Mondragon J, Frank C, Murphy C, et al
    Examining functional connectivity in metabolic syndrome and small vessel disease: A novel approach to understanding olfactory dysfunction and Alzheimer's disease.
    Brain Res. 2025 Dec 1:150084. doi: 10.1016/j.brainres.2025.150084.
    

    >> Share

    
    November 2025
12. HUI S, Long Y, Zhu L, Shi W, et al
    IGF2BP2-mediated m6A modification of IGF1R mRNA promotes neuronal senescence and cognitive decline in Alzheimer's disease.
    Brain Res. 2025;1871:150067.
    

    >> Share

    
    
13. SARDARI M, Sahafi OH, Rezayof A
    Mitochondria serve as indispensable components of neuron-glia crosstalk in the trajectory of Alzheimer's disease.
    Brain Res. 2025 Nov 18:150040. doi: 10.1016/j.brainres.2025.150040.
    

    >> Share

    
    
14. VLACHOS I, Moschovos C, Apostolakopoulou L, Karasavvidou K, et al
    Resting EEG partial coherence demonstrates increased gamma range central functional connectivity in amnestic mild cognitive impairment.
    Brain Res. 2025;1867:149973.
    

    >> Share

    
    
15. SHARMA A, Singh TG
    Next-generation neurotherapeutics: mechanistic insights on monoclonal antibodies in Alzheimer's disease.
    Brain Res. 2025;1870:150047.
    

    >> Share

    
    October 2025
16. LIU Z, Kuang L, Zhou X, Zhao J, et al
    Effect of the plasma lipidome, immune cells, inflammatory proteins, gut microbiota, and plasma metabolites on Alzheimer's Disease: A two-sample Mendelian randomized study and mediation analysis.
    Brain Res. 2025;1869:150009.
    

    >> Share

    
    
17. BI D, Gao B, Shen Y, Dai Z, et al
    Traumatic brain injury and neurodegenerative diseases: the role of axonal injury and amyloid-beta.
    Brain Res. 2025;1865:149873.
    

    >> Share

    
    
18. ISMAIL A, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, et al
    Astrocyte response in Alzheimer's disease: Good or bad?
    Brain Res. 2025 Oct 6:149971. doi: 10.1016/j.brainres.2025.149971.
    

    >> Share

    
    
19. DING Z, Wang J, Ding W, Duan Y, et al
    Calycosin improved long-term memory impairment in the very early of APP/PS1 mice.
    Brain Res. 2025;1864:149789.
    

    >> Share

    
    
20. GENG D, Liu A, Yan Y, Zheng W, et al
    Intermittent ELF-MF exposure effectively ameliorates pathologic features associated with adult AD mice.
    Brain Res. 2025;1864:149796.
    

    >> Share

    
    September 2025
21. WANG Y, Zhao D, Kong T, Ni Y, et al
    Associations between reproductive milestones and Alzheimer's disease risk: a Mendelian randomization study.
    Brain Res. 2025;1867:149972.
    

    >> Share

    
    
22. KAKOTY V, Goh KW, Kesharwani P, Ko YT, et al
    BNIP3L/NIX-mediated mitophagy: Future directions in Alzheimer's disease.
    Brain Res. 2025;1867:149970.
    

    >> Share

    
    
23. MAK KK, Nam KJ, Chuang YF, Chen LK, et al
    Matrix metalloproteinases and tissue inhibitors of metalloproteinases as the biomarkers of Alzheimer's disease: a meta-analysis.
    Brain Res. 2025 Sep 23:149954. doi: 10.1016/j.brainres.2025.149954.
    

    >> Share

    
    
24. AKASH A, Ahamed M, Porel P, Aran KR, et al
    Galectin-3 in Alzheimer's disease: pathological roles, biomarker potential, and therapeutic implications.
    Brain Res. 2025 Sep 19:149949. doi: 10.1016/j.brainres.2025.149949.
    

    >> Share

    
    
25. HU X, Morihara R, Fukui Y, Bian Y, et al
    Spearmint extract Neumentix downregulates amyloid-beta accumulation by promoting phagocytosis in APP23 mice.
    Brain Res. 2025;1863:149752.
    

    >> Share

    
    
26. SHENG J, Zhu H, Zhou R, Zhang Q, et al
    Bridging the gap between structural and metabolic neuroimaging via MRI-to-PET synthesis: A tri-attention enhanced GAN approach.
    Brain Res. 2025;1862:149691.
    

    >> Share

    
    August 2025
27. CAM OZUNLU SA, Uysal F, Tatli Dogan H, Parlar A, et al
    Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer's disease.
    Brain Res. 2025;1866:149918.
    

    >> Share

    
    
28. LI J, Wang C, Zhang JH, Cai JM, et al
    Expression of concern: "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress" [BRAIN RES, Volume 1328 (2010) 152-161].
    Brain Res. 2025;1861:149685.
    

    >> Share

    
    
29. MOHAN M, Mannan A, Singh S, Singh TG, et al
    Unlocking the cellular mystery: how proton pump inhibitors may alter the dementia landscape.
    Brain Res. 2025;1861:149702.
    

    >> Share

    
    
30. LIU B, Ahmad MA, Abbas G, Ahmed U, et al
    From particulates to pathways: environmental exposures and their impact on Alzheimer's disease.
    Brain Res. 2025 Aug 8:149880. doi: 10.1016/j.brainres.2025.149880.
    

    >> Share

    
    
31. LIU L, Jiang M, Zhang Y, Lv L, et al
    Acori Tatarinowii Rhizoma inhibited neuroinflammation in Alzheimer's disease rats by modulating the intestinal flora.
    Brain Res. 2025 Aug 8:149878. doi: 10.1016/j.brainres.2025.149878.
    

    >> Share

    
    July 2025
32. ALOUANI Z, Gannour OE, Saleh S, El-Ibrahimi A, et al
    A novel contrastive Dual-Branch Network (CDB-Net) for robust EEG-Based Alzheimer's disease diagnosis.
    Brain Res. 2025;1865:149863.
    

    >> Share

    
    
33. WANG Y, Mu D, Li Y, Liu C, et al
    Alzheimer's disease: a jigsaw puzzle comprised of different types of programmed cell death pieces.
    Brain Res. 2025;1865:149861.
    

    >> Share

    
    
34. ISLAM MA, Kshirsagar S, Alvir RV, Pradeepkiran JA, et al
    Overexpressed MicroRNA-455-3p enhances cognitive function in late-onset Alzheimer's disease.
    Brain Res. 2025 Jul 21:149853. doi: 10.1016/j.brainres.2025.149853.
    

    >> Share

    
    
35. YAO M, Liu A, Song J, Xing L, et al
    The impact of epigenetic and epitranscriptomic modifications on Alzheimer's disease: the mysteries of DNA, RNA, and histone methylation.
    Brain Res. 2025;1865:149852.
    

    >> Share

    
    
36. SALGADO KDCB, Nascimento RGF, Albuquerque ALS, Oliveira LAM, et al
    Melatonin protects mouse hippocampal neurons from neurotoxicity induced by amyloid beta-peptide(25-35).
    Brain Res. 2025;1859:149637.
    

    >> Share

    
    
37. BASHIR DJ, Bhat KA, Bashir M
    Deciphering Alzheimer's disease: Molecular mechanisms, preclinical models and strategies to overcome Blood-Brain-Barrier.
    Brain Res. 2025;1863:149828.
    

    >> Share

    
    
38. BALL BK, Kuhn MK, Fleeman Bechtel RM, Proctor EA, et al
    Metabolites associated with type 2 diabetes and Alzheimer's disease trigger differential intracellular signaling responses in mouse primary neurons.
    Brain Res. 2025;1864:149819.
    

    >> Share

    
    June 2025
39. HE J, Ran M, Tam KY
    An orally administered quinolinium molecule mitigates neuropathology of Alzheimer's disease through modulation of mitochondrial dysfunction and neuroinflammation.
    Brain Res. 2025 Jun 25:149804. doi: 10.1016/j.brainres.2025.149804.
    

    >> Share

    
    
40. MA XH, Dai H, Liu SY, Liu XN, et al
    Protection of dauricine and daurisoline on PC12 cells damaged by glutamate or Abeta(25-35).
    Brain Res. 2025;1857:149609.
    

    >> Share

    
    
41. KHAN G, Hussain MS, Khan Y, Fatima R, et al
    Ferroptosis and its contribution to cognitive impairment in Alzheimer's disease: mechanisms and therapeutic potential.
    Brain Res. 2025 Jun 9:149776. doi: 10.1016/j.brainres.2025.149776.
    

    >> Share

    
    May 2025
42. ARIOZ BI, Binokay L, Tastan B, Genc B, et al
    Characterization of tRNA-derived fragments in the small neuron-derived extracellular vesicles of Alzheimer's disease patients.
    Brain Res. 2025;1862:149730.
    

    >> Share

    
    
43. CHAVEZ-LOPEZ LM, Silvestre-Martinez JH, Del Carmen Lugo-Ibarra K, Castro-Cesena AB, et al
    A comprehensive approach to Alzheimer's Disease: Exploring Nanotechnology, treatment Innovations, and sex differences.
    Brain Res. 2025 May 26:149718. doi: 10.1016/j.brainres.2025.149718.
    

    >> Share

    
    
44. YANG X, Jiang M, Wu M, Jin X, et al
    Crocin drives intestinal microbiota variation in a rat model of Alzheimer's disease by reducing DKK3 expression.
    Brain Res. 2025;1862:149734.
    

    >> Share

    
    
45. ZHOU Q, Huang X, Chen Z, Wang F, et al
    Mechanism of Rhizoma Polygonati in the treatment of Alzheimer's disease based on network pharmacology and molecular docking.
    Brain Res. 2025 May 22:149680. doi: 10.1016/j.brainres.2025.149680.
    

    >> Share

    
    
46. SOLEIMANI Z, Davoudi S, Saffarzadeh F, Behzadi G, et al
    Restoring neuronal excitability and spatial memory through inhibiting amyloid-beta-induced hyperactive NF-kappaB in a rat model of Alzheimer's disease.
    Brain Res. 2025;1861:149703.
    

    >> Share

    
    
47. KAUR J, Sharma V, Khan H, Singh S, et al
    Intersecting molecular pathways in Synucleinopathies and Amyloidogenesis: Exploring shared mechanisms and therapeutic potential.
    Brain Res. 2025;1855:149568.
    

    >> Share

    
    
48. SHAHID F, Khan R, Mehmood A, Smadi AA, et al
    A comprehensive approach to anticipating the progression of mild cognitive impairment.
    Brain Res. 2025;1855:149549.
    

    >> Share

    
    
49. XU C
    Enhanced social interaction protects cognition by preserving synapse numbers.
    Brain Res. 2025;1854:149552.
    

    >> Share

    
    April 2025
50. MIYAZAKI H, Ide K, Yamaguchi H, Ogawa M, et al
    Peripheral lymphocyte counts and regional cerebral blood flow on brain SPECT correlate in Alzheimer's disease: A retrospective cross-sectional study.
    Brain Res. 2025;1859:149657.
    

    >> Share

    
    
51. AHSAN R, Khan MM, Mishra A, Noor G, et al
    Plumbagin as a potential therapeutic agent for scopolamine-induced Alzheimer's disease: Mechanistic insights into GSK-3beta inhibition.
    Brain Res. 2025 Apr 16:149650. doi: 10.1016/j.brainres.2025.149650.
    

    >> Share

    
    
52. FANG L, Fu X, Yu Y, Liu D, et al
    Collaborative multitasking framework for enhanced hippocampus segmentation and Alzheimer's disease classification.
    Brain Res. 2025;1858:149610.
    

    >> Share

    
    
53. AKBARI F, Soheilian R, Tavalaeian S, Zamani A, et al
    Alterations in NFAT5 and ATP6V1E1 expression as potential diagnostic biomarkers in blood and brain for Alzheimer's disease: A study of gene overlap.
    Brain Res. 2025 Apr 3:149599. doi: 10.1016/j.brainres.2025.149599.
    

    >> Share

    
    
54. RADBAKHSH S, Abrego-Guandique DM, Bacchetti T, Aghaee-Bakhtiari SH, et al
    Direct hybridization and bioinformatics analysis of circulating microRNAs in patients with Alzheimer's disease under intravenous trehalose treatment.
    Brain Res. 2025;1857:149607.
    

    >> Share

    
    
55. CHIANG MC, Nicol CJB, Yang YP, Chiang T, et al
    The alpha-MG exhibits neuroprotective potential by reducing amyloid beta peptide-induced inflammation, oxidative stress, and tau aggregation in human neural stem cells.
    Brain Res. 2025;1852:149506.
    

    >> Share

    
    March 2025
56. KARIM F, Ngo A, Danh TB, Delaney BA, et al
    Reduction in [(18)F]Nifene Binding, a PET imaging Probe for alpha4beta2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer's disease brain.
    Brain Res. 2025;1857:149600.
    

    >> Share

    
    
57. KAZEMI M, Sanati M, Shekari Khaniani M, Ghafouri-Fard S, et al
    A review on the lncRNA-miRNA-mRNA regulatory networks involved in inflammatory processes in Alzheimer's disease.
    Brain Res. 2025;1856:149595.
    

    >> Share

    
    
58. JAIN S, Murmu A, Chauhan A
    Advancing Alzheimer's disease therapy through engineered exosomal Macromolecules.
    Brain Res. 2025;1855:149590.
    

    >> Share

    
    
59. PINKY, Anwar S, Neha, Parvez S, et al
    Paeoniflorin inhibits pyruvate dehydrogenase kinase 3 and promotes BDNF activity by modulating neuronal activity and TNF-alpha.
    Brain Res. 2025;1851:149476.
    

    >> Share

    
    
60. ABDEL-AAL RA, Meligy FY, Maghraby N, Sayed N, et al
    Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer's activity in aluminum chloride-induced Alzheimer's-like disease in rats: Impact on alpha7 nicotinic acetylcholine receptors and amyloid beta.
    Brain Res. 2025;1855:149573.
    

    >> Share

    
    
61. ZHENG C, Zhao Y, Hu C, Zhang L, et al
    Transcriptomic and network analysis identifies shared pathways across Alzheimer's disease and vascular dementia.
    Brain Res. 2025 Mar 3:149548. doi: 10.1016/j.brainres.2025.149548.
    

    >> Share

    
    
62. DERAFSHPOUR L, Niazi M, Pourheydar B, Roshan-Milani S, et al
    Aging and voluntary exercise's effects on Abeta1-42 levels, endoplasmic reticulum stress factors, and apoptosis in the hippocampus of old male rats.
    Brain Res. 2025;1850:149447.
    

    >> Share

    
    
63. GUTIERRE RC, Rocha PR, Graciani AL, Coppi AA, et al
    Tau, amyloid, iron, oligodendrocytes ferroptosis, and inflammaging in the hippocampal formation of aged rats submitted to an aerobic exercise program.
    Brain Res. 2025;1850:149419.
    

    >> Share

    
    
64. WANG R, Azad AK, Sheikh AM, Tabassum S, et al
    Carboxylated Zn-phthalocyanine attenuates brain Abeta in AD model mouse.
    Brain Res. 2025;1850:149422.
    

    >> Share

    
    February 2025
65. GHADGE SR, Shimpi PH, Kumbhar VV, Khairnar B, et al
    Comprehensive evaluation of AChE inhibition by Eulophia ochreata extract Utilizing in Silico, ex Vivo, and in vivo zebrafish models.
    Brain Res. 2025 Feb 24:149531. doi: 10.1016/j.brainres.2025.149531.
    

    >> Share

    
    
66. TIAN Y, Li W, Zhang Y
    3-N-Butylphthalide alleviate Abeta-induced cellular senescence through the CDK2-pRB1-Caspase3 axis.
    Brain Res. 2025;1849:149435.
    

    >> Share

    
    
67. WANG L, Li W, Wu W, Liu Q, et al
    Effects of electroacupuncture on microglia phenotype and epigenetic modulation of C/EBPbeta in SAMP8 mice.
    Brain Res. 2025;1849:149339.
    

    >> Share

    
    
68. ZHAO X, Zhou Q, Zhang H, Ono M, et al
    Olfactory deprivation promotes amyloid beta deposition in a mouse model of Alzheimer's disease.
    Brain Res. 2025;1851:149500.
    

    >> Share

    
    
69. DHAPOLA R, Kumari S, Sharma P, Vellingiri B, et al
    Advancements in autophagy perturbations in Alzheimer's disease: Molecular aspects and therapeutics.
    Brain Res. 2025;1851:149494.
    

    >> Share

    
    January 2025
70. LI W, Yong-Yan X, Jia-Xin M, Shu-Chao G, et al
    Senescent microglia: The hidden culprits accelerating Alzheimer's disease.
    Brain Res. 2025 Jan 28:149480. doi: 10.1016/j.brainres.2025.149480.
    

    >> Share

    
    
71. CHIARINI A, Armato U, Gui L, Yin M, et al
    Early divergent modulation of NLRP2's and NLRP3's inflammasome sensors vs. AIM2's one by signals from Abeta.Calcium-sensing receptor complexes in human astrocytes.
    Brain Res. 2025;1846:149283.
    

    >> Share

    
    December 2024
72. ZHANG Z, Zhang S, Liu S, He Y, et al
    Fuzhisan ameliorates cognitive ability in Alzheimer's disease by p62 and related autophagy regulatory pathways.
    Brain Res. 2024;1849:149436.
    

    >> Share

    
    
73. YANG Q, Chen T, Li S, Yang C, et al
    Inhibition of autophagy attenuates cognitive decline and mitochondrial dysfunction in an Alzheimer's disease mouse model with chronic cerebral hypoperfusion.
    Brain Res. 2024;1850:149416.
    

    >> Share

    
    
74. XIE Y, Yang M, Wang H, Chen Y, et al
    Potential molecular mechanisms of tobacco smoke exposure in Alzheimer's disease.
    Brain Res. 2024;1848:149394.
    

    >> Share

    
    
75. CHEN J, Zhang M, Shen Z, Tang M, et al
    Low-dose diazepam improves cognitive function in APP/PS1 mouse models: Involvement of AMPA receptors.
    Brain Res. 2024;1845:149207.
    

    >> Share

    
    
76. DE SOUSA RAL, Mendes BF
    T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses.
    Brain Res. 2024;1850:149393.
    

    >> Share

    
    
77. SUN S, Cui C, Li Y, Meng Y, et al
    A Machine learning classification framework using fused fractal property feature vectors for Alzheimer's disease diagnosis.
    Brain Res. 2024 Dec 3:149373. doi: 10.1016/j.brainres.2024.149373.
    

    >> Share

    
    November 2024
78. CHEN Z, Zheng N, Wang F, Zhou Q, et al
    The role of ferritinophagy and ferroptosis in Alzheimer's disease.
    Brain Res. 2024 Nov 23:149340. doi: 10.1016/j.brainres.2024.149340.
    

    >> Share

    
    
79. LIN L, Li J, Yu Z, He J, et al
    Nrf2 activator tertiary butylhydroquinone enhances neural stem cell differentiation and implantation in Alzheimer's disease by boosting mitochondrial function.
    Brain Res. 2024 Nov 18:149341. doi: 10.1016/j.brainres.2024.149341.
    

    >> Share

    
    
80. PATTANAIK S, Prusty SK, Sahu PK
    Exploring DPP IV inhibitors for Alzheimer's disease: Bridging diabetes and neurodegeneration.
    Brain Res. 2024 Nov 18:149342. doi: 10.1016/j.brainres.2024.149342.
    

    >> Share

    
    
81. MAHMUD JOY MA, Nasrin S, Siddiqua A, Farid DM, et al
    ViTAD: Leveraging Modified Vision Transformer for Alzheimer's Disease Multi-Stage Classification from Brain MRI Scans.
    Brain Res. 2024 Nov 11:149302. doi: 10.1016/j.brainres.2024.149302.
    

    >> Share

    
    
82. ZHANG T, Yang J, Xu H, Cao Y, et al
    Acorus tatarinowii alleviates D-galactose-induced Alzheimer's-like disease cognitive impairment and Abeta-induced pericytes dysfunction in mice.
    Brain Res. 2024 Nov 6:149312. doi: 10.1016/j.brainres.2024.149312.
    

    >> Share

    
    
83. DING X, Liu F, Wang H, Wang Y, et al
    Ganoderic acid a decreased Abeta42-induced neurotoxicity in PC12 cells by reduced mitochondrial damage.
    Brain Res. 2024;1842:149102.
    

    >> Share

    
    
84. DIVYA R, Shantha Selva Kumari R
    Multi-instance learning attention model for amyloid quantification of brain sub regions in longitudinal cognitive decline.
    Brain Res. 2024;1842:149103.
    

    >> Share

    
    October 2024
85. SEREBROVSKA Z, Xi L, Fedoriuk M, Dosenko V, et al
    Intermittent hypoxia-hyperoxia training ameliorates cognitive impairment and neuroinflammation in a rat model of Alzheimer's disease.
    Brain Res. 2024 Oct 28:149301. doi: 10.1016/j.brainres.2024.149301.
    

    >> Share

    
    
86. GANESH A, Choudhury W, Coutellier L
    Early spatial recognition memory deficits in 5XFAD female mice are associated with disruption of prefrontal parvalbumin neurons.
    Brain Res. 2024;1841:149122.
    

    >> Share

    
    
87. XIA N, Xu L, Xu D, Huang M, et al
    Neuroprotective effect of emodin on Abeta(25-35)-induced cytotoxicity in PC12 cells involves Nrf2/GPX4 and TLR4/p-NF-kappaB/NLRP3 pathways.
    Brain Res. 2024;1841:149019.
    

    >> Share

    
    
88. MAFTOON H, Davar Siadat S, Tarashi S, Soroush E, et al
    Ameliorative effects of Akkermansia muciniphila on anxiety-like behavior and cognitive deficits in a rat model of Alzheimer's disease.
    Brain Res. 2024 Oct 15:149280. doi: 10.1016/j.brainres.2024.149280.
    

    >> Share

    
    
89. PARKER J, Moris JM, Goodman LC, Paidisetty VK, et al
    A multifactorial lens on risk factors promoting the progression of Alzheimer's disease.
    Brain Res. 2024;1846:149262.
    

    >> Share

    
    September 2024
90. ASADIFARD E, Hokmabadi M, Hashemi M, Bereimipour A, et al
    Linking gut microbiota dysbiosis to molecular pathways in Alzheimer's disease.
    Brain Res. 2024 Sep 16:149242. doi: 10.1016/j.brainres.2024.149242.
    

    >> Share

    
    
91. WANG W, Xia H
    The role of lipid species in Alzheimer's disease onset: A comprehensive Mendelian randomization analysis.
    Brain Res. 2024 Sep 13:149238. doi: 10.1016/j.brainres.2024.149238.
    

    >> Share

    
    
92. HAN R, Zhang X, Chen Y, Hou X, et al
    Associations between differential connectivity patterns of executive control networks and APOE varepsilon4 in the Alzheimer continuum.
    Brain Res. 2024 Sep 8:149229. doi: 10.1016/j.brainres.2024.149229.
    

    >> Share

    
    August 2024
93. THAPA R, Ahmad Bhat A, Shahwan M, Ali H, et al
    Proteostasis disruption and senescence in Alzheimer's disease pathways to neurodegeneration.
    Brain Res. 2024;1845:149202.
    

    >> Share

    
    
94. ZHANG QX, Zhang LJ, Zhao N, Yang L, et al
    Irisin in ischemic Stroke, Alzheimer's disease and Depression: A narrative review.
    Brain Res. 2024 Aug 28:149192. doi: 10.1016/j.brainres.2024.149192.
    

    >> Share

    
    
95. SINGH M, Ali H, Renuka Jyothi S, Kaur I, et al
    Tau proteins and senescent Cells: Targeting aging pathways in Alzheimer's disease.
    Brain Res. 2024;1844:149165.
    

    >> Share

    
    
96. ZHONG F, Xiong L, Wu J, Chen Y, et al
    The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer's disease.
    Brain Res. 2024 Aug 19:149173. doi: 10.1016/j.brainres.2024.149173.
    

    >> Share

    
    
97. BREEZE B, Connell E, Wileman T, Muller M, et al
    Menopause and Alzheimer's disease susceptibility: Exploring the potential mechanisms.
    Brain Res. 2024 Aug 18:149170. doi: 10.1016/j.brainres.2024.149170.
    

    >> Share

    
    
98. MCCLARTY BM, Rodriguez G, Dong H
    Class 1 histone deacetylases differentially modulate memory and synaptic genes in a spatial and temporal manner in aged and APP/PS1 mice.
    Brain Res. 2024;1837:148951.
    

    >> Share

    
    July 2024
99. SMITH T, Knudsen KJ, Ritchie SA
    A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer's disease.
    Brain Res. 2024 Jul 23:149132. doi: 10.1016/j.brainres.2024.149132.
    

    >> Share

    
    
100. ABUDUAINI Y, Chen W, Kong XZ
     Handedness in Alzheimer's disease: A systematic review.
     Brain Res. 2024 Jul 23:149131. doi: 10.1016/j.brainres.2024.149131.
     

     >> Share

     
     June 2024
101. SUN S, Lu W, Zhang C, Wang G, et al
     Folic acid and S-adenosylmethionine reverse Homocysteine-induced Alzheimer's disease-like pathological changes in rat hippocampus by modulating PS1 and PP2A methylation levels.
     Brain Res. 2024 Jun 23:149095. doi: 10.1016/j.brainres.2024.149095.
     

     >> Share

     
     
102. DE LOURDES SIGNORINI-SOUZA I, Tureck LV, Batistela MS, Coutinho de Almeida R, et al
     The potential of five c-miRNAs as serum biomarkers for Late-Onset Alzheimer's disease diagnosis: miR-10a-5p, miR-29b-2-5p, miR-125a-5p, miR-342-3p, and miR-708-5p.
     Brain Res. 2024 Jun 14:149090. doi: 10.1016/j.brainres.2024.149090.
     

     >> Share

     
     
103. RUSSO ML, Ayala G, Neal D, Rogalsky AE, et al
     Alzheimer's-linked axonal changes accompany elevated antidromic action potential failure rate in aged mice.
     Brain Res. 2024 Jun 10:149083. doi: 10.1016/j.brainres.2024.149083.
     

     >> Share

     
     
104. WANG Y, Wu LH, Hou F, Wang ZJ, et al
     Mitochondrial calcium uniporter knockdown in hippocampal neurons alleviates anxious and depressive behavior in the 3XTG Alzheimer's disease mouse model.
     Brain Res. 2024 Jun 6:149060. doi: 10.1016/j.brainres.2024.149060.
     

     >> Share

     
     May 2024
105. FARHATULLAH, Chen X, Zeng D, Mehmood A, et al
     3-Way hybrid analysis using clinical and magnetic resonance imaging for early diagnosis of Alzheimer's disease.
     Brain Res. 2024 May 27:149021. doi: 10.1016/j.brainres.2024.149021.
     

     >> Share

     
     
106. BHADANE P, Roul K, Belemkar S, Kumar D, et al
     Immunotherapeutic approaches for Alzheimer's disease: Exploring active and passive vaccine progress.
     Brain Res. 2024 May 21:149018. doi: 10.1016/j.brainres.2024.149018.
     

     >> Share

     
     
107. ZHOU Q, Xu L
     The regulation of BAI1 in astrocytes through the STAT3/EZH2 axis relieves neuronal apoptosis in rats with Alzheimer's disease.
     Brain Res. 2024;1839:149007.
     

     >> Share

     
     
108. LIU X, Chen J, Du Y, Tian Q, et al
     The changes of neurogenesis in the hippocampal dentate gyrus of SAMP8 mice and the effects of acupuncture and moxibustion.
     Brain Res. 2024;1831:148814.
     

     >> Share

     
     
109. CHEN Y, Li Y, Wu M, Li Z, et al
     Electroacupuncture improves cognitive function in APP/PS1 mice by inhibiting oxidative stress related hippocampal neuronal ferroptosis.
     Brain Res. 2024;1831:148744.
     

     >> Share

     
     
110. FU Y, Xie GM, Liu RQ, Xie JL, et al
     From aberrant neurodevelopment to neurodegeneration: Insights into the hub gene associated with autism and alzheimer's disease.
     Brain Res. 2024;1838:148992.
     

     >> Share

     
     
111. CHANG CJ, Taoufiq Z, Yamada H, Kohji T, et al
     The microtubule-dynamin binding inhibitor peptide PHDP5 rescues spatial learning and memory deficits in Alzheimer's disease model mice.
     Brain Res. 2024 May 6:148987. doi: 10.1016/j.brainres.2024.148987.
     

     >> Share

     
     
112. PEI MQ, Xu LM, Yang YS, Chen WC, et al
     Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders.
     Brain Res. 2024;1830:148821.
     

     >> Share

     
     
113. HE R, Al-Tamimi J, Sanchez-Benavides G, Montana-Valverde G, et al
     Atypical cortical hierarchy in Abeta-positive older adults and its reflection in spontaneous speech.
     Brain Res. 2024;1830:148806.
     

     >> Share

     
     April 2024
114. FOROUGHI S, Shahanipour K, Monajemi R, Ahadi AM, et al
     Investigating the effects of Thymus vulgaris essential oil, Allium cepa extract, and their active compounds (thymol and quercetin) on expression profile of genes related to Alzheimer's disease in PC12 model cell.
     Brain Res. 2024 Apr 28:148966. doi: 10.1016/j.brainres.2024.148966.
     

     >> Share

     
     
115. NEFODOVA A, Rudyk M, Dovhyi R, Dovbynchuk T, et al
     Systemic inflammation in Abeta(1-40)-induced Alzheimer's disease model: New translational opportunities.
     Brain Res. 2024;1837:148960.
     

     >> Share

     
     
116. XIE Y, Li X, Shi Q, Le L, et al
     The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer's disease.
     Brain Res. 2024;1837:148959.
     

     >> Share

     
     
117. BEIYU Z, Rong Z, Yi Z, Shan W, et al
     Oxidative stress is associated with Abeta accumulation in chronic sleep deprivation model.
     Brain Res. 2024;1829:148776.
     

     >> Share

     
     
118. CLELAND NRW, Potter GJ, Buck C, Quang D, et al
     Altered metabolism and DAM-signatures in female brains and microglia with aging.
     Brain Res. 2024;1829:148772.
     

     >> Share

     
     
119. HAN L, Chen W, Li J, Zhao Y, et al
     Palmatine improves cognitive dysfunction in Alzheimer's disease model rats through autophagy pathway and regulation of gut microbiota.
     Brain Res. 2024;1835:148932.
     

     >> Share

     
     
120. UCHIUMI O, Zou J, Yamaki S, Hori Y, et al
     Disruption of sphingomyelin synthase 2 gene alleviates cognitive impairment in a mouse model of Alzheimer's disease.
     Brain Res. 2024;1835:148934.
     

     >> Share

     
     
121. YANG Y, Jia X, Yang X, Wang J, et al
     Targeting VDAC: A potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
     Brain Res. 2024;1835:148920.
     

     >> Share

     
     
122. REZAUL ISLAM M, Akash S, Murshedul Islam M, Sarkar N, et al
     Alkaloids as drug leads in Alzheimer's treatment: Mechanistic and therapeutic insights.
     Brain Res. 2024 Apr 4:148886. doi: 10.1016/j.brainres.2024.148886.
     

     >> Share

     
     
123. KUSHAWAHA SK, Ashawat MS, Soni D, Kumar P, et al
     Aurothioglucose encapsulated nanoparticles fostered neuroprotection in streptozotocin-induced Alzheimer's disease.
     Brain Res. 2024;1834:148906.
     

     >> Share

     
     March 2024
124. KAUR K, Kulkarni YA, Wairkar S
     Exploring the potential of quercetin in Alzheimer's Disease: Pharmacodynamics, Pharmacokinetics, and Nanodelivery systems.
     Brain Res. 2024;1834:148905.
     

     >> Share

     
     
125. ANSARI MA, Al-Jarallah A, Rao MS, Babiker A, et al
     Upregulation of NADPH-oxidase, inducible nitric oxide synthase and apoptosis in the hippocampus following impaired insulin signaling in the rats: Development of sporadic Alzheimer's disease.
     Brain Res. 2024;1834:148890.
     

     >> Share

     
     
126. GENG C, Tan L, Chenchen
     Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias.
     Brain Res. 2024 Mar 20:148881. doi: 10.1016/j.brainres.2024.148881.
     

     >> Share

     
     
127. WANG Y, Song C, Yin G, Meng Y, et al
     Alleviation of behavioral deficits, amyloid-beta deposition, and mitochondrial structure damage associated with mitophagy upregulation in AD animal models via AAV9-IGF-1 treatment.
     Brain Res. 2024;1827:148743.
     

     >> Share

     
     
128. LIU R, Guo L, Zhao Y, Wu D, et al
     Study on multi-target effects of the novel HDAC6 inhibitor W5 on Abeta/Cu(2+)-induced Alzheimer's disease model of rats.
     Brain Res. 2024;1832:148847.
     

     >> Share

     
     
129. MERCERON-MARTINEZ D, Alacan Ricardo L, Bejerano Pina A, Orama Rojo N, et al
     Amylovis-201 enhances physiological memory formation and rescues memory and hippocampal cell loss in a streptozotocin-induced Alzheimer's disease animal model.
     Brain Res. 2024 Mar 1:148848. doi: 10.1016/j.brainres.2024.148848.
     

     >> Share

     
     February 2024
130. WANG W, Zheng WQ, Du X, Chen SC, et al
     Chronic pain exacerbates memory impairment and pathology of Abeta and tau by upregulating IL-1beta and p-65 signaling in a mouse model of Alzheimer's disease.
     Brain Res. 2024 Feb 29:148843. doi: 10.1016/j.brainres.2024.148843.
     

     >> Share

     
     
131. ZHANG Z, Ding C, Fu R, Wang J, et al
     Low-frequency rTMS modulated the excitability and high-frequency firing in hippocampal neurons of the Alzheimer's disease mouse model.
     Brain Res. 2024 Feb 24:148822. doi: 10.1016/j.brainres.2024.148822.
     

     >> Share

     
     
132. PUMO A, Legeay S
     The dichotomous activities of microglia: A potential driver for phenotypic heterogeneity in Alzheimer's disease.
     Brain Res. 2024 Feb 21:148817. doi: 10.1016/j.brainres.2024.148817.
     

     >> Share

     
     
133. MANTELLATTO GRIGOLI M, Pelegrini LNC, Whelan R, Cominetti MR, et al
     Present and Future of Blood-Based Biomarkers of Alzheimer's Disease: Beyond the Classics.
     Brain Res. 2024;1830:148812.
     

     >> Share

     
     
134. SHARMA M, Pal P, Gupta SK
     The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons.
     Brain Res. 2024;1829:148797.
     

     >> Share

     
     
135. DHEVII MANOHARAN S, Abdul Hamid H, Fariesha Md Hashim N, Singh Cheema M, et al
     Could protein phosphatase 2A and glycogen synthase kinase-3 beta be targeted by natural compounds to ameliorate Alzheimer's pathologies?
     Brain Res. 2024 Feb 1:148793. doi: 10.1016/j.brainres.2024.148793.
     

     >> Share

     
     January 2024
136. TSAMOU M, Roggen EL
     Sex-associated microRNAs potentially implicated in sporadic Alzheimer's disease (sAD).
     Brain Res. 2024 Jan 31:148791. doi: 10.1016/j.brainres.2024.148791.
     

     >> Share

     
     
137. LANDIN-ROMERO R, Kumfor F, Ys Lee A, Leyton C, et al
     Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing.
     Brain Res. 2024;1829:148777.
     

     >> Share

     
     
138. ZHAI Y, Morihara R, Feng T, Hu X, et al
     Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3/PIM1/NFATc1 axis, in a novel mouse model of Alzheimer's disease with cerebral hypoperfusion.
     Brain Res. 2024 Jan 23:148790. doi: 10.1016/j.brainres.2024.148790.
     

     >> Share

     
     
139. VALIPOUR B, Simorgh S, Mirsalehi M, Moradi S, et al
     Improvement of spatial learning and memory deficits by intranasal administration of human olfactory ecto-mesenchymal stem cells in an Alzheimer's disease rat model.
     Brain Res. 2024;1828:148764.
     

     >> Share

     
     
140. BELVIRANLI M, Okudan N
     Coconut oil ameliorates behavioral and biochemical alterations induced by D-GAL/AlCl(3) in rats.
     Brain Res. 2024;1823:148704.
     

     >> Share

     
     
141. MAJOU D, Dermenghem AL
     Effects of DHA (omega-3 fatty acid) and estradiol on amyloid beta-peptide regulation in the brain.
     Brain Res. 2024;1823:148681.
     

     >> Share

     
     
142. CHEN H, Yang X, Gao Y, Jiang H, et al
     Electroacupuncture ameliorates cognitive impairment in APP/PS1 mouse by modulating TFEB levels to relieve ALP dysfunction.
     Brain Res. 2024;1823:148683.
     

     >> Share

     
     
143. CHEN P, Zhang S, Zhao K, Kang X, et al
     Robustly uncovering the heterogeneity of neurodegenerative disease by using data-driven subtyping in neuroimaging: A review.
     Brain Res. 2024;1823:148675.
     

     >> Share

     
     
144. KEIL J, Kiiski H, Doherty L, Hernandez-Urbina V, et al
     Artificial sharp-wave-ripples to support memory and counter neurodegeneration.
     Brain Res. 2024;1822:148646.
     

     >> Share

     
     December 2023
145. MIAO J, Liu X, Lan J
     40 Hz Electroacupuncture relieves the memory dysfunction of 5xFAD mice by regulating neuronal electrical activity.
     Brain Res. 2023;1821:148576.
     

     >> Share

     
     
146. YANG Y, Wang J, Ni H, Ding H, et al
     Genetic model of selective COX2 inhibition improve learning and memory ability and brain pathological changes in 5xFAD mouse.
     Brain Res. 2023;1821:148566.
     

     >> Share

     
     
147. YU H, Morihara R, Ota-Elliott R, Bian Z, et al
     Injection of exogenous amyloid-beta oligomers aggravated cognitive deficits, and activated necroptosis, in APP23 transgenic mice.
     Brain Res. 2023;1821:148565.
     

     >> Share

     
     
148. WANG X, Gan W, Kang M, Lv C, et al
     Asthma aggravates alzheimer's disease by up-regulating NF- kappaB signaling pathway through LTD4.
     Brain Res. 2023 Dec 11:148711. doi: 10.1016/j.brainres.2023.148711.
     

     >> Share

     
     November 2023
149. AMIR A, Shahid M, Farooq Khan S, Nisar U, et al
     Nicotinic acid modulates microglial TREM-2 gene in Phytohaemagglutinin-Induced in vitro model of Alzheimer's disease like pathology.
     Brain Res. 2023;1824:148686.
     

     >> Share

     
     
150. WANG Y, Gong Q, Pan H, Wang X, et al
     Gardenia jasminoides J. Ellis extract attenuates memory impairment in rats with Alzheimer's disease by suppressing NLRP3 inflammasome.
     Brain Res. 2023;1824:148687.
     

     >> Share

     
     October 2023
151. XIAOMEI L, Tianyuyi F, Erheng C, Li Y, et al
     A rat model established by simulating genetic-environmental interactions recapitulates human Alzheimer's disease pathology.
     Brain Res. 2023 Oct 31:148663. doi: 10.1016/j.brainres.2023.148663.
     

     >> Share

     
     
152. HASHEMI SA, Ghadimi Z, Ghaedi H, Hashemi A, et al
     The effect of eight weeks of aerobic training with vitamin C on the expression pathway of antioxidants in the hippocampus tissue of TMT induced Alzheimer's disease rats.
     Brain Res. 2023 Oct 21:148645. doi: 10.1016/j.brainres.2023.148645.
     

     >> Share

     
     
153. HENRY SM, Kistler SA, Lagani GD, Bartling CRO, et al
     Tight control of the APP-Mint1 interaction in regulating amyloid production.
     Brain Res. 2023;1817:148496.
     

     >> Share

     
     
154. MOAZZAM F, Hatamian-Zarmi A, Ebrahimi Hosseinzadeh B, Khodagholi F, et al
     Preparation and characterization of brain-targeted polymeric nanocarriers (Frankincense-PMBN-lactoferrin) and in-vivo evaluation on an Alzheimer's disease-like rat model induced by scopolamine.
     Brain Res. 2023;1822:148622.
     

     >> Share

     
     
155. MALIK R, Kalra S, Pooja, Singh G, et al
     Antioxidative and neuroprotective potential of Acorus calamus linn. and Cordia dichotoma G. Forst. In Alzheimer's type dementia in rodent.
     Brain Res. 2023 Oct 2:148616. doi: 10.1016/j.brainres.2023.148616.
     

     >> Share

     
     September 2023
156. LIAN X, Zhang X, Chen W, Xue F, et al
     Dexmedetomidine mitigates neuroinflammation in an Alzheimer's disease mouse model via the miR-204-3p/FBXL7 signaling axis.
     Brain Res. 2023 Sep 29:148612. doi: 10.1016/j.brainres.2023.148612.
     

     >> Share

     
     
157. ASAMU MO, Oladipo OO, Abayomi OA, Adebayo AA, et al
     Alzheimer's disease: The role of T lymphocytes in neuroinflammation and neurodegeneration.
     Brain Res. 2023 Sep 19:148589. doi: 10.1016/j.brainres.2023.148589.
     

     >> Share

     
     
158. ARULCHELVAN E, Vanneste S
     Promising neurostimulation routes for targeting the hippocampus to improve episodic memory: A review.
     Brain Res. 2023;1815:148457.
     

     >> Share

     
     August 2023
159. WANG Y, Shen Z, Wu H, Yu Z, et al
     Identification of genes related to glucose metabolism and analysis of the immune characteristics in Alzheimer's disease.
     Brain Res. 2023 Aug 22:148545. doi: 10.1016/j.brainres.2023.148545.
     

     >> Share

     
     
160. MISHRA M, Raik S, Rattan V, Bhattacharyya S, et al
     Mitochondria transfer as a potential therapeutic mechanism in Alzheimer's disease-like pathology.
     Brain Res. 2023 Aug 22:148544. doi: 10.1016/j.brainres.2023.148544.
     

     >> Share

     
     
161. ADEKUNLE BABALOLA J, Lang M, George M, Stracke A, et al
     Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer's disease-related blood brain barrier dysfunction and inflammation.
     Brain Res. 2023 Aug 12:148518. doi: 10.1016/j.brainres.2023.148518.
     

     >> Share

     
     
162. QIN Y, Bai D, Tang M, Zhang M, et al
     Ketogenic diet alleviates brain iron deposition and cognitive dysfunction via Nrf2-mediated ferroptosis pathway in APP/PS1 mouse.
     Brain Res. 2023;1812:148404.
     

     >> Share

     
     June 2023
163. CHAVAN RS, Supalkar KV, Sadar SS, Vyawahare NS, et al
     ANIMAL MODELS OF ALZHEIMER'S DISEASE: AN ORIGINOF INNOVATIVETREATMENTS AND INSIGHT TO THE DISEASE'S ETIOLOGY.
     Brain Res. 2023 Jun 9:148449. doi: 10.1016/j.brainres.2023.148449.
     

     >> Share

     
     
164. KOSE S, Kutlu MD, Kara S, Polat S, et al
     Investigation of the protective effect of long-term exercise on molecular pathways and behaviours in scopolamine induced alzheimer's disease-like condition.
     Brain Res. 2023 Jun 1:148429. doi: 10.1016/j.brainres.2023.148429.
     

     >> Share

     
     May 2023
165. HASAN SMN, Clarke C, Strand T, Bambico FR, et al
     Putative pathological mechanisms of late-life depression and Alzheimer's disease.
     Brain Res. 2023;1813:148423.
     

     >> Share

     
     April 2023
166. CORIA-LUCERO C, Castro A, Ledezma C, Leporatti J, et al
     An intracerebroventricular injection of ABeta (1-42) modifies temporal profiles of spatial memory performance and oxidative status in the temporal cortex rat.
     Brain Res. 2023;1804:148242.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share